Mihály Józan-Jilling1, Iván Horváth, Ernó Kis
1Tolna Megyei Onkormányzat Balassa János Kórháza, Szekszárd, Kardiológiai Osztály.
This study shows that a combined half dose of alteplase (tissue plasminogen activator) and eptifibatide is an effective and safe treatment for acute coronary syndromes. This approach offers a viable alternative for patients requiring urgent revascularization.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: